Beginning with the production of penicillin in 1946, Meiji Seika Pharma has established itself as a leader in the manufacture and sale of antibacterial drugs. The company also supplies high …
Meiji Seika Pharma Co., Ltd. begins operation to succeed the pharmaceutical business of the former Meiji Seika Kaisha Ltd, following a reorganization of companies within the Meiji Group. …
Meiji Seika Pharma Opens New Office in Boston Area to Pursue . Investment Opportunities in Innovative Drugs and Technologies . Tokyo, Japan –August 8, 2024– Meiji Seika Pharma Co. …
2024年11月11日 · Meiji Group's drug development pipeline ranges from areas of core expertise through to follow-on biologics, generic anti-cancer drugs, and agrochemicals.
Meiji is responding to global vaccine demand with our approved influenza, hepatitis and Japanese encephalitis vaccines, plus combined vaccines and single-supply vaccines for which no …
Meiji Seika Pharma obtained exclusive rights to distribute KostaiveTM in Japan from CSL Seqirus*2 on April 11, 2023, and is collaborating with ARCALIS, Inc.*3 to establish integrated …
Meiji Seika Pharma's generic drug business enables wider treatment options for many common conditions, from infectious diseases and CNS disorders to digestive and lifestyle-related …
Making Japan's Dairy Industry More Sustainable. Meiji Group Calculates Greenhouse Gas Emissions from Milk Production; Awards Honor Employees Exemplifying Meiji's Pursuit of …